1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Characteristics of patients with different changing patterns of thrombus length
Thrombus Shortening (n = 14)Thrombus without Change (n = 19)Thrombus Extension (n = 18)P Value
Age (yr) (mean)62.79 ± 14.7467.53 ± 13.4770.44 ± 11.63.275
Women (No.) (%)4 (28.6)7 (36.8)9 (50).480
Comorbid conditions
    Atrial fibrillation (No.) (%)7 (50)9 (47.4)10 (55.6).938
    Hypertension (No.) (%)10 (71.4)15 (78.9)16 (88.9).502
    Diabetes (No.) (%)1 (7.1)2 (10.5)5 (27.8).245
    Hyperlipidemia (No.) (%)10 (71.4)10 (52.6)8 (44.4).316
    Smoking (No.) (%)7 (50)10 (52.6)6 (33.3).461
Clinical variables
    NIHSS score (range)6.5 (4.5–11.75)11 (7–16)16 (13–18)<.001
    Onset to imaging (mean) (min)201.43 ± 98.09233.58 ± 139.42175.28 ± 67.20.263
    Previous antiplatelet use (No.) (%)2 (14.3)4 (21.1)1 (6.6).406
    Platelets (109/L) (mean)189.50 ± 84.43200.89 ± 98.60179.94 ± 42.89.723
    INR (mean)1.07 ± 0.141.02 ± 0.071.01 ± 0.08.229
Baseline thrombus length (range) (mm)12.99 (6.93–18.74)8.0 (3.3–11.10)13.31 (6.35–17.59).116
Baseline ATD (range) (sec)3.24 (1.71–5.42)2.77 (0.90–4.48)7.24 (3.52–9.18).001
Peak score of collaterals (range)3 (1–3)3 (1–3)1 (0–2).001
tMIP score of collaterals (range)3 (1–3)3 (2–3)2 (1–3).176
Poor outcome (No.) (%)7 (50)16 (84.2)18 (100).001
  • Note:—INR indicates international normalized ratio.